BRAIN MAX
BRAIN MAX, licence 80124903: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- TimeOut Tribe Inc
- NPN or DIN-HM
- 80124903
- Status
- Active licence
- Licence date
- 12 June 2023
- Revision date
- 19 February 2024
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Phosphatidylsérine Source : Phosphatidylserine | 100.0 mg | Not calculated |
| Panax ginseng Source : Panax ginseng - racine | 75.0 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Dichlorhydrate d'arginate d'acétyle-L-carnitine | 700.0 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Dry plant equivalent : 4000 mg Potency : 6.0 % Terpene lactones | 40.0 mg | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 24.0 % Flavonoid glycosides | Not specified | Not calculated |
| Bacopa monnieri Source : Bacopa monnieri - Sommité (herbe) | 125.0 mg | Not calculated |
| L-Tyrosine Source : L-Tyrosine ethyl ester | 3500.0 mg | Not calculated |
Non-medicinal ingredients
Laque d'aluminium bleu FD&C n° 1, Saveur, Maltodextrine, Acide citrique, Rouge FD&C N° 40
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Mesures | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support cognitive health and/or brain function. Helps to decrease cognitive fatigue due to physically stressful situations (e.g. extended wakefulness, exposure to cold, excessive noise). Helps to enhance cognitive function and/or memory in adults. (Provides) An antioxidant. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80124903
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.